Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: 5,17,37,5,101,... who wrote (161)	1/1/1999 10:45:00 PM
From: tnsaf	Read Replies (1) of 2515

I came across this thread while looking for treatments for pancreatic cancer. In response to your comment <<I can't say except that maybe C225, because it is a taxol based drug, will have to compete with a myriad of other taxol based drugs out there>>, note that C225 is a monoclonal antibody and is being used in combination with radiation or various chemotherapy agents, so it isn't competing with taxol. Jason

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next